Amgen Close to Buying Onyx Pharmaceuticals for $125/Share -NY TImes
The New York Times is reporting that Amgen (NASDAQ: AMGN) is close to a deal to acquire Onyx Pharmaceuticals (NASDAQ: ONXX) for $125 per share. The deal could be announced on Monday, according to sources.
Onyx rejected an offer of $120 per share from Amgen. Onyx Pharmaceuticals closed Friday at $116.96.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.